In This Issue
Spring Fever Anyone?
Just like spring flowers, in-person events are opening up BY DAWN MC FARLAND Conference season is back for our industry, following two years of staying at home — holy moly! And I wouldn’t change a […]
In This Issue
In This Issue
3 Questions Proactive Brokers Are Asking About Compensation Disclosure
New disclosure requires extra step for brokers BY TOM AVERY here’s a new federal broker compensation disclosure requirement that’s encouraging greater transparency in the benefits industry — and creating an extra step for brokers. The […]
In This Issue
Everyone Has a Money Story
Understanding one’s relationship with money is essential to financial literacy BY WINONA HAVIR My “Nâi nai,” (grandmother) realized that if her children remained in China they would all be killed. She found passage for them, […]
In This Issue
Group Benefit Brokers 101 to Help Clients With Succession Planning For business owners “failing to plan is planning to fail”
A CONVERSATION BETWEEN PHIL CALHOUN AND DANNIEL WEXLER Phil Calhoun: Danny, your law career has specialized in and focused on estate planning — mostly for business owners. With the many business owners that you’ve worked […]
In This Issue
PHARMACY Carve-in vs. Carve-out:
How Unbundling Pharmacy Benefits Can Reduce Costs and Improve Health Outcomes BY CHRIS BROWN healthcare costs continue to rise year after year. While employers experienced the smallest increase in decades during the COVID-19 pandemic as […]
In This Issue
Rx for High Specialty Drug Costs
UNDERSTANDING COST DRIVERS AND MANAGEMENT STRATEGIES BY JOHN THORNTON Pharmaceuticals have been rising in cost steadily, but none greater than specialty drugs (i.e., those typically prescribed by a specialist, are often intravenously administered, and require […]